ngµç×ÓÓÎÏ·ÐÂÎÅѶ£¨Í¨Ñ¶Ô±ÌÆÑÞÀö£©¼××´ÏÙÏà¹ØÑÛ²¡£¡£¨TAO£©ÊÇÒ»ÖÖ³£¼ûµÄÃâÒßÑ×Ö¢ÐÔÑÛ¿ô²¡£¬£¬µ«¼¤ËØ¡¢¡¢¡¢ÃâÒßÒÖÖÆ¼Á¡¢¡¢¡¢ÉúÎïÖÆ¼ÁÖÎÁƸ±×÷Óô󣬣¬ngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄÁºµ¤½ÌÊÚÍŶÓͨ¹ýÑо¿£¬£¬Ê×´ÎÌá³öµÍ¼ÁÁ¿Ç¿Á¦Ã¹ËØÄÜÓÐÓÃÖÎÁÆÇá¶ÈTAO£¬£¬ÕâһЧ¹û½«ÎªÇá¶ÈTAO»¼ÕßÌṩ¾¼Ã¡¢¡¢¡¢Çå¾²µÄÖÎÁÆ·½°¸£¬£¬Ô츣¿í´óÇá¶ÈTAO»¼Õß¡£¡£
¼××´ÏÙÏà¹ØÑÛ²¡£¡£¨Thyroid-associated Ophthalmopathy, TAO£©ÊÇÒ»ÖÖ³£¼ûµÄÃâÒßÑ×Ö¢ÐÔÑÛ¿ô²¡£¬£¬·¢²¡ÂʾӳÉÈËÑÛ¿ô²¡Ê×λ¡£¡£Ñ×Ö¢ÀÛ¼°ÑÛÍ⼡¡¢¡¢¡¢ÑÛ¿ôÖ¬·¾µÈÈí×éÖ¯£¬£¬µ¼ÖÂÉÏíúÍËËõ¡¢¡¢¡¢ÑÛÇòÍ»³ö¡¢¡¢¡¢ÊÓÎïÖØÓ°µÈÁÙ´²¸Ä±ä£¬£¬ÑÏÖØÕß¿ÉÖÂä¡£¡£Æ¾Ö¤¼²²¡ÑÏÖØ³Ì¶È¿É½«TAO·ÖΪÇá¶È¡¢¡¢¡¢ÖÐÖØ¶È¼°ÊÓÁ¦ÍþвÐÍ£¬£¬ÆäÖÐÇá¶ÈTAO»¼ÕßÁè¼Ý70%¡£¡£Î·¹â¡¢¡¢¡¢Á÷Àá¡¢¡¢¡¢ÊÓÎïÄ£º£ºýÒÔ¼°ÑÛÇòÍ»³ö¡¢¡¢¡¢ÉÏíúÍËËõµÈÐÎ×´¸Ä±äµÈ³ÖÐøÀ§ÈÅÇá¶ÈTAO»¼Õߣ¬£¬ÑÏÖØÓ°Ï컼ÕßµÄÉíÐÄ¿µ½¡¡£¡£±ðµÄ£¬£¬Ô¼80%µÄÇá¶È»¼Õß²¡Çé³ÖÐø»òÏòÖÐÖØ¶ÈÏ£Íû£¬£¬ÐèÒªÆð¾¢¾ÙÐиÉÔ¤¡£¡£È»¶ø£¬£¬¼øÓÚ¼¤ËØ¡¢¡¢¡¢ÃâÒßÒÖÖÆ¼Á¡¢¡¢¡¢ÉúÎïÖÆ¼Á¸±×÷Óô󣬣¬ÏÖÔÚÖ¸ÄÏÈÔ½¨Òé½ÓÄÉÆÚ´ýÊÓ²ìµÄÖÎÁÆÕ½ÂÔ¡£¡£Òò´Ë£¬£¬Ñ°ÕÒ¸±×÷ÓÃС¡¢¡¢¡¢ÓÐÓõÄÇá¶ÈTAOÖÎÁÆÊֶξßÓÐÖ÷ÒªµÄÁÙ´²ÒâÒå¡£¡£
Ç¿Á¦Ã¹ËØÊÇËÄ»·ËØÀ࿹ÉúËØ¡£¡£¼ÈÍùÎÒÃÇ¿ÎÌâ×éµÄÑо¿·¢Ã÷£¬£¬×ÔÁ¦ÓÚ¿¹¾úЧӦ֮Í⣬£¬µÍ¼ÁÁ¿Ç¿Á¦Ã¹ËؾßÓÐÃâÒßµ÷Àí¹¦Ð§£¬£¬ÄÜÓÐÓÃÖÎÁÆÑÛ±íÃâÒßÑ×Ö¢£¬£¬Í¬Ê±ÓÐÓÃÖÎÁÆÖÐÖØ¶ÈTAO¡£¡£ÎÄÏ×Ò²±¨µÀ£¬£¬Ç¿Á¦Ã¹ËØ¿ÉÒÔÓÐÓÃÖÎÁÆ·çʪÐÔÊàŦÑס¢¡¢¡¢ÀàÌìðå´¯¡¢¡¢¡¢¶à·¢ÐÔÓ²»¯µÈ¶àÖÖÃâÒßÑ×Ö¢ÐÔ¼²²¡¡£¡£Îª´Ë£¬£¬ÏîÄ¿×éÆô¶¯ÁËÒ»Ïî¶àÖÐÐÄ¡¢¡¢¡¢Ëæ»ú¡¢¡¢¡¢Ë«Ã¤¡¢¡¢¡¢Î¿½å¼Á±ÈÕÕÁÙ´²Ñо¿£¨RCT£©£¬£¬Ì½Ë÷µÍ¼ÁÁ¿Ç¿Á¦Ã¹ËØÄÜ·ñÓÐÓÃÖÎÁÆÇá¶ÈTAO¡£¡£
¸ÃÑо¿ÓÉÎÒÖÐÐÄÁºµ¤½ÌÊÚǣͷ£¬£¬Ñо¿ÔÚngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄ¡¢¡¢¡¢ÖÐÄÏ´óÑ§ÏæÑÅÒ½Ôº¡¢¡¢¡¢ÉϺ£½»Í¨´óѧÁ¥ÊôµÚ¾ÅÒ½Ôº¡¢¡¢¡¢±±¾©ÐºÍÒ½ÔºÒÔ¼°¸£½¨Ê¡Ê¡Á¢Ò½ÔºµÈÎåÆäÖÐÐÄ¿ªÕ¹£¬£¬¹²ÄÉÈë100ÃûÇкÏÈë×éÌõ¼þµÄÇá¶ÈTAO»¼Õߣ¬£¬ÒÔ1:1µÄ±ÈÀýËæ»ú·ÖÅ䏸ÓèÖðÈÕ¿Ú·þ50ºÁ¿ËÇ¿Á¦Ã¹ËØ»òο½å¼Á£¬£¬Á½×é¸÷50Àý»¼Õߣ¬£¬Á¬Ðø·þÓÃ12ÖÜ£¬£¬Í¨¹ý˫äÊÓ²ì½ÏÁ¿Á½Õß»¼Õß12ÖܵĺÃתÂÊ£¬£¬ÆÀ¹ÀÇ¿Á¦Ã¹ËضÔÇá¶ÈTAOµÄÖÎÁÆÐ§¹û¡£¡£
Ñо¿Ð§¹ûÅú×¢£º£ºÔÚµÚ12ÖÜ£¬£¬Ïà¹ØÓÚο½å¼Á×飬£¬Ç¿Á¦Ã¹ËØÖÎÁÆ×é¾ßÓнϸߵÄÁÙ´²ºÃתÂÊ£¨38% VS 16%£¬£¬ P=0.014£¬£¬¼ûͼ1£©¡£¡£ÕâһЧ¹ûÅú×¢£¬£¬Á¬Ðø12ÖÜÌìÌì¿Ú·þ50mgÇ¿Á¦Ã¹ËØÄܹ»ÓÐÓÃÖÎÁÆÇá¶ÈTAO»¼Õߣ¬£¬¸ÄÉÆÆäÁÙ´²Ö¢×´¡£¡£±ðµÄ£¬£¬±¾Ñо¿»¹Ê״ᨵÀÁËÑÇÖÞÇá¶ÈTAO»¼ÕßµÄ×ÔÈ»ºÃתÂÊ£¬£¬ÕâһЧ¹û¶ÔÁÙ´²Ò½Éú¾öÒéÖÎÁÆ·½°¸¡¢¡¢¡¢¿ªÕ¹Ïà¹ØÑо¿ÌṩÁËÖ÷ÒªÒÀ¾Ý¡£¡£

ͼ1£º£ºÑо¿Ð§¹û¼°Æäͳ¼ÆÆÊÎö¡£¡£ÔÚITTÖУ¬£¬½ÓÄÉCochran-Mantel-HaenszelÄ¥Á·£¬£¬ºÃתÂÊΪǿÁ¦Ã¹ËØ×飨38.0%£©VS ο½å¼Á×飨16.0%£©£¬£¬P= 0.01¡£¡£
Ç¿Á¦Ã¹ËØ×÷ΪһÖֹŰåµÄÀÏÒ©£¬£¬ÆäÇå¾²ÐÔÒÑ»ñµÃ³ä·ÖµÄÁÙ´²ÑéÖ¤¡£¡£ÎÒÃÇʹÓõļÁÁ¿ÊÇ¿¹¾ú¼ÁÁ¿(200mg/Ìì)µÄ1/4£¬£¬±¾Ñо¿ÊÓ²ìÁËʹÓÃ3¸öÔµIJ»Á¼·´Ó³¡£¡£ÔÚÇ¿Á¦Ã¹ËØ×éÓÐÒ»Àý»¼Õß·ºÆðÇá¶ÈµÄθ²¿²»ÊÊ£¬£¬ÔÚ·þÓÃÖÊ×Ó±ÃÒÖÖÆ¼ÁºóºÃת²¢ÇÒÍê³É12ÖܵÄÒ©Îï¸ÉÔ¤¡£¡£ÕâÅú×¢£¬£¬Á¬Ðø12ÖܿڷþµÍ¼ÁÁ¿µÄÇ¿Á¦Ã¹ËؾßÓнϺõÄÇå¾²ÐÔ¡£¡£

ͼ2£º£ºÇ¿Á¦Ã¹ËØ×éÒ»Àý»¼Õß°éÓÐÇá¶È賦µÀ²»ÊÊ£¬£¬Í¨¹ý»¤Î¸ÖÎÁÆÍê³ÉºóÐøÑо¿£¬£¬ÌáÐÑÏÔʾǿÁ¦Ã¹ËØÇå¾²ÐÔÓÅÒì¡£¡£
Áºµ¤½ÌÊÚÍŶÓͨ¹ýRCTÑо¿£¬£¬Ê×´ÎÌá³öµÍ¼ÁÁ¿Ç¿Á¦Ã¹ËØÄÜÓÐÓÃÖÎÁÆÇá¶ÈTAO£¬£¬ÕâһЧ¹û½«ÎªÇá¶ÈTAO»¼ÕßÌṩÁËÇå¾²µÄÖÎÁÆ·½°¸¡£¡£Ç¿Á¦Ã¹ËؼÛÇ®×ÔÖÆ£¬£¬Äܱ»¿í´ó»¼ÕßËù½ÓÊÜ£¬£¬ÕâÖÖеÄÖÎÁÆ·½°¸±Ø½«Ô츣Çá¶ÈTAO»¼Õß¡£¡£Î´À´£¬£¬ÍŶӻ¹½«ÔÚ±¾¿ÎÌâµÄ»ù´¡ÉÏ£¬£¬¿ªÕ¹½øÒ»²½µÄÁÙ´²Ñо¿£¬£¬ÊÓ²ìÌá¸ßÇ¿Á¦Ã¹ËؼÁÁ¿ºÍ/»òÑÓÉìÖÎÁÆÊ±¼äÄÜ·ñ½øÒ»²½Ìá¸ßÁÆÐ§¡£¡£
ÖµµÃÒ»ÌáµÄÊÇ£¬£¬¸ÃÑо¿»¹»ñµÃÁËÔÓÖ¾µÄͬÆÚÊöÆÀ£¬£¬ÆÀ¼ÛÆð¾¢¿Í¹Û£¬£¬ÍâÑóÙÉÐгä·Ö¿Ï¶¨Á˸ÃÑо¿µÄ¿ÆÑ§¼ÛÖµºÍÉîÔ¶µÄÁÙ´²ÒâÒå¡£¡£
ÒÔÉÏÑо¿Ð§¹ûÓÚ2022Äê9ÔÂ29ÈÕ½ÒÏþÓÚJAMA Ophthalmology¡£¡£ngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄÁºµ¤½ÌÊÚΪͨѶ×÷Õߣ¬£¬ÅËæÂ¡¢¡¢¡¢³ÂخϪ¡¢¡¢¡¢Õލ¡¢¡¢¡¢ÁÖÃîÀö¡¢¡¢¡¢Áõ×ÆË¸ÎªÅäºÏµÚÒ»×÷Õß¡£¡£ngµç×ÓÓÎÏ·ÖÐɽÑÛ¿ÆÖÐÐÄ¡¢¡¢¡¢ÑÛ¿ÆÑ§¹ú¼ÒÖØµãʵÑéÊÒΪµÚÒ»µ¥Î»£¬£¬ÖÐÄÏ´óÑ§ÏæÑÅÒ½Ôº¡¢¡¢¡¢ÉϺ£½»Í¨´óѧÁ¥ÊôµÚ¾ÅÒ½Ôº¡¢¡¢¡¢±±¾©ÐºÍÒ½ÔºÒÔ¼°¸£½¨Ê¡Ê¡Á¢Ò½ÔºÎªÏàÖúµ¥Î»¡£¡£
ÂÛÎÄÁ´½Ó£º£º
https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2796841
ͬÆÚÊöÆÀÁ´½Ó£º£º
https://jamanetwork.com/journals/jamaophthalmology/article-abstract/2796845